Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.882 | 0.240 | 3 | 9750423 | missense variant | G/A;C | snv | 2.2E-03; 4.0E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 0 | ||||||||||
|
1.000 | 0.040 | 3 | 9760752 | missense variant | G/A | snv |
|
Neoplasms | 0.700 | 0 | |||||||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Neoplasms; Respiratory Tract Diseases | 0.100 | 0.967 | 30 | 1999 | 2019 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Neoplasms; Respiratory Tract Diseases | 0.100 | 0.967 | 30 | 1999 | 2019 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Neoplasms; Respiratory Tract Diseases | 0.100 | 0.967 | 30 | 1999 | 2019 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Neoplasms | 0.100 | 0.955 | 22 | 2002 | 2018 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Neoplasms | 0.100 | 0.955 | 22 | 2002 | 2018 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Digestive System Diseases; Neoplasms | 0.100 | 0.500 | 18 | 2005 | 2019 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.100 | 0.944 | 18 | 2002 | 2019 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.100 | 0.944 | 18 | 2002 | 2019 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Digestive System Diseases; Neoplasms | 0.100 | 0.800 | 15 | 2001 | 2017 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Digestive System Diseases; Neoplasms | 0.100 | 0.786 | 14 | 2001 | 2017 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
0.100 | 0.538 | 13 | 2005 | 2015 | |||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Neoplasms; Male Urogenital Diseases | 0.070 | 0.857 | 7 | 2003 | 2015 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.070 | 0.857 | 7 | 2007 | 2014 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Neoplasms; Male Urogenital Diseases | 0.070 | 0.857 | 7 | 2003 | 2015 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Digestive System Diseases; Neoplasms | 0.070 | 1.000 | 7 | 2006 | 2019 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.070 | 0.857 | 7 | 2007 | 2014 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.070 | 0.857 | 7 | 2007 | 2014 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Nervous System Diseases; Mental Disorders | 0.060 | 1.000 | 6 | 2007 | 2019 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases | 0.050 | 1.000 | 5 | 2006 | 2013 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Neoplasms | 0.050 | 1.000 | 5 | 2002 | 2012 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.050 | 1.000 | 5 | 2009 | 2014 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Neoplasms; Respiratory Tract Diseases | 0.050 | 1.000 | 5 | 2006 | 2019 | ||||||
|
0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.040 | 1.000 | 4 | 2005 | 2019 |